SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-15-004273
Filing Date
2015-05-15
Accepted
2015-05-15 17:03:06
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q q1201510q.htm 10-Q 553444
2 EXHIBIT 31.1 q12015-exhibit311.htm EX-31.1 15907
3 EXHIBIT 31.2 q12015-exhibit312.htm EX-31.2 15916
4 EXHIBIT 32.1 q12015-exhibit321.htm EX-32.1 8188
  Complete submission text file 0001628280-15-004273.txt   3207497

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpix-20141231.xml EX-101.INS 331746
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20141231.xsd EX-101.SCH 26817
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20141231_cal.xml EX-101.CAL 47577
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20141231_def.xml EX-101.DEF 90107
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20141231_lab.xml EX-101.LAB 325687
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20141231_pre.xml EX-101.PRE 179349
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 15870669
SIC: 2834 Pharmaceutical Preparations